Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Biomatter Secures $18 Million for AI-Powered Enzyme Design
Biotech & Bioprocessing Biomatter Secures $18 Million for AI-Powered Enzyme Design

Suboptimal enzymes have long been the industry standard because the technology to design specific target reactions from scratch was previously unavailable. This technical ceiling has restricted progress across the pharmaceutical and agricultural sectors for decades, forcing scientists to rely on

New Framework Bridges Gap in Plant-Derived Drug Discovery
Tech & Innovation New Framework Bridges Gap in Plant-Derived Drug Discovery

A structured evaluative framework is now necessary to standardize the assessment of plant-derived anti-inflammatory compounds and their therapeutic potential. Historically, the field of pharmacology has leaned heavily on natural products as the bedrock of discovery, yet the journey from a bioactive

Can Placental Cell Therapy Heal Chronic Diabetic Foot Ulcers?
Research & Development Can Placental Cell Therapy Heal Chronic Diabetic Foot Ulcers?

The ethical use of healthy, full-term placental tissue provides a unique source of stem-like cells possessing vital immunomodulatory properties for patient safety, and this therapeutic approach has recently gained significant traction as a viable solution for one of the most stubborn challenges in

How Should Medical Schools Govern AI in Scientific Writing?
Tech & Innovation How Should Medical Schools Govern AI in Scientific Writing?

Formal disclosure requirements for prompt logs and manuscript influence vary widely across the academic landscape, leaving many authors without clear guidance. As medical universities increasingly rely on sophisticated generative tools to streamline complex research workflows, the boundaries of

Can Stem Cells Improve Survival in Viral Lung Injury?
Research & Development Can Stem Cells Improve Survival in Viral Lung Injury?

A comprehensive meta-analysis of 24 randomized controlled trials indicates that mesenchymal stem cell therapy can reduce the risk of death by 36% in patients suffering from viral lung injury. This revelation comes at a critical time when traditional supportive care often struggles to keep pace with

AI Mitochondrial Interactome Mapping – Review
Tech & Innovation AI Mitochondrial Interactome Mapping – Review

Modern metabolic research has long been stymied by the fact that nearly one-third of the proteins residing within human mitochondria remain functionally anonymous, leaving critical gaps in the understanding of how cellular energy translates into physiological health or systemic disease. This

How AI Is Transforming Pharmaceutical Drug Discovery
Research & Development How AI Is Transforming Pharmaceutical Drug Discovery

The focus on precision medicine ensures that clinical trials are no longer derailed by non-responders who do not fit a drug's specific biological mechanism. This paradigm shift characterizes the current state of the pharmaceutical industry in 2026, where the historical reliance on serendipity and

How Does Immune Repertoire Profiling Change Medicine?
Tech & Innovation How Does Immune Repertoire Profiling Change Medicine?

Monitoring the skewed B-cell repertoires of patients with Systemic Lupus Erythematosus offers a non-invasive way to track disease flares and the efficacy of immunosuppressive treatments, representing a critical part of a larger movement in 2026 toward precision immunogenomics. The medical community

ALLO-329 Shows Rapid Benefits for Systemic Sclerosis
Research & Development ALLO-329 Shows Rapid Benefits for Systemic Sclerosis

ALLO-329 Shows Rapid Benefits for Systemic Sclerosis, an experimental therapy that utilizes healthy donor cells to create an available, pre-manufactured product designed to address the high cost and logistical hurdles of cell therapy. Systemic sclerosis, a devastating autoimmune condition often

A Guide to DAVID Bioinformatics for Gene List Annotation
Tech & Innovation A Guide to DAVID Bioinformatics for Gene List Annotation

Commercial and academic users alike can access the analysis workspace for free to find genes or generate comprehensive gene list reports for their publications. Modern high-throughput sequencing generates massive datasets that require sophisticated interpretation to uncover underlying biological

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later